404 related articles for article (PubMed ID: 30837904)
1. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
Chye Y; Christensen E; Solowij N; Yücel M
Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and substance use disorder: Dream or reality.
Karimi-Haghighi S; Razavi Y; Iezzi D; Scheyer AF; Manzoni O; Haghparast A
Neuropharmacology; 2022 Apr; 207():108948. PubMed ID: 35032495
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
[TBL] [Abstract][Full Text] [Related]
4. Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.
Navarrete F; García-Gutiérrez MS; Gasparyan A; Austrich-Olivares A; Manzanares J
Front Pharmacol; 2021; 12():626010. PubMed ID: 34093179
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targets of Cannabidiol in Neurological Disorders.
Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
[TBL] [Abstract][Full Text] [Related]
6. Do Cannabis and Cannabinoids Have a Psychopharmacotherapeutic Effect?
Pajević I; Hasanović M; Žigić N; Pajević A; Avdić L
Psychiatr Danub; 2021; 33(Suppl 4):1196-1203. PubMed ID: 35354187
[TBL] [Abstract][Full Text] [Related]
7. An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects.
Martinez Naya N; Kelly J; Corna G; Golino M; Polizio AH; Abbate A; Toldo S; Mezzaroma E
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257386
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
Schonhofen P; Bristot IJ; Crippa JA; Hallak JEC; Zuardi AW; Parsons RB; Klamt F
CNS Drugs; 2018 Aug; 32(8):697-712. PubMed ID: 30109642
[TBL] [Abstract][Full Text] [Related]
9. Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
Pelz MC; Schoolcraft KD; Larson C; Spring MG; López HH
Epilepsy Behav; 2017 Aug; 73():111-118. PubMed ID: 28624721
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the endocannabinoid system in drug addiction.
Maldonado R; Valverde O; Berrendero F
Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol in the context of substance use disorder treatment: A systematic review.
Paulus V; Billieux J; Benyamina A; Karila L
Addict Behav; 2022 Sep; 132():107360. PubMed ID: 35580370
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
Razavi Y; Keyhanfar F; Shabani R; Haghparast A; Mehdizadeh M
Iran J Pharm Res; 2021; 20(4):152-164. PubMed ID: 35194436
[TBL] [Abstract][Full Text] [Related]
13. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
14. Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation.
Stern CAJ; de Carvalho CR; Bertoglio LJ; Takahashi RN
Neuroscience; 2018 Feb; 370():62-80. PubMed ID: 28729064
[TBL] [Abstract][Full Text] [Related]
15. The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders.
Luján MÁ; Valverde O
Front Behav Neurosci; 2020; 14():109. PubMed ID: 32676014
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
[TBL] [Abstract][Full Text] [Related]
17. Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
Hurd YL; Yoon M; Manini AF; Hernandez S; Olmedo R; Ostman M; Jutras-Aswad D
Neurotherapeutics; 2015 Oct; 12(4):807-15. PubMed ID: 26269227
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries.
Aychman MM; Goldman DL; Kaplan JS
Front Neurol; 2023; 14():1087011. PubMed ID: 36816569
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.
Staben J; Koch M; Reid K; Muckerheide J; Gilman L; McGuinness F; Kiesser S; Oswald IWH; Koby KA; Martin TJ; Kaplan JS
Front Neurosci; 2023; 17():1185737. PubMed ID: 37397463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
